X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6043) 6043
Publication (940) 940
Book Review (198) 198
Book Chapter (70) 70
Book / eBook (50) 50
Newsletter (31) 31
Newspaper Article (23) 23
Dissertation (11) 11
Conference Proceeding (7) 7
Magazine Article (3) 3
Transcript (2) 2
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (4338) 4338
humans (4281) 4281
hepatitis (2478) 2478
animals (2274) 2274
proteins (1559) 1559
viruses (1517) 1517
research article (1402) 1402
male (1331) 1331
medicine (1323) 1323
female (1279) 1279
health aspects (1244) 1244
infections (1231) 1231
mice (1226) 1226
immunology (1225) 1225
research (1218) 1218
gene expression (1158) 1158
virology (1156) 1156
liver (1147) 1147
multidisciplinary sciences (1145) 1145
hepatitis c virus (1071) 1071
science (1033) 1033
infection (923) 923
hepatitis c (903) 903
virus diseases (895) 895
liver diseases (889) 889
expression (863) 863
microbiology (828) 828
biology (827) 827
middle aged (820) 820
digestive system diseases (806) 806
signal transduction (775) 775
adult (761) 761
rodents (757) 757
cell biology (756) 756
apoptosis (752) 752
interferon (721) 721
liver cancer (717) 717
infectious diseases (714) 714
genetic aspects (701) 701
cell line (691) 691
inflammation (690) 690
hepatocellular carcinoma (671) 671
cytokines (668) 668
hepatitis-c virus (667) 667
cancer (650) 650
physiological aspects (629) 629
activation (620) 620
analysis (608) 608
review (608) 608
replication (576) 576
kinases (571) 571
biochemistry & molecular biology (564) 564
hepatitis b virus (558) 558
viral infections (553) 553
article (539) 539
hepatitis b (532) 532
cell line, tumor (515) 515
rna (511) 511
genomes (510) 510
oncology (507) 507
gastroenterology & hepatology (501) 501
studies (496) 496
development and progression (488) 488
medicine, research & experimental (479) 479
hepatocytes (478) 478
pathogenesis (478) 478
immune response (471) 471
biochemistry (467) 467
lymphocytes (463) 463
risk factors (461) 461
aged (460) 460
immune system (460) 460
hepatocellular-carcinoma (452) 452
medical research (428) 428
t cells (424) 424
disease (422) 422
care and treatment (416) 416
hepacivirus - physiology (414) 414
cells (412) 412
immunity (410) 410
liver - metabolism (410) 410
metabolism (409) 409
cells, cultured (405) 405
gastroenterology and hepatology (403) 403
antigens (394) 394
genes (393) 393
biology and life sciences (384) 384
patients (383) 383
hepatology (381) 381
hepatoma (375) 375
mice, inbred c57bl (371) 371
gene-expression (366) 366
medicine and health sciences (361) 361
deoxyribonucleic acid--dna (359) 359
dendritic cells (350) 350
fibrosis (349) 349
oxidative stress (344) 344
liver - pathology (336) 336
hepacivirus - genetics (335) 335
liver cirrhosis (333) 333
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6194) 6194
Chinese (16) 16
Japanese (4) 4
Spanish (3) 3
Korean (2) 2
Arabic (1) 1
French (1) 1
Portuguese (1) 1
Romanian (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Gastroenterology, ISSN 0016-5085, 10/2017, Volume 153, Issue 4, pp. 1107 - 1119.e10
Ligand binding to inhibitory receptors on immune cells, such as programmed cell death 1 (PD-1) and cytotoxic T-lymphocyte associated protein 4 (CTLA4),... 
GPC3 | MAGEC2 | Immunotherapy | Galectin 9 | SAFETY | CANCER | RESPONSES | ADVANCED MELANOMA | PEPTIDE-MHC | NIVOLUMAB | GASTROENTEROLOGY & HEPATOLOGY | UP-REGULATION | PD-1 | TETRAMERS | EXHAUSTION | Tumor Escape - drug effects | Antigens, CD - immunology | Up-Regulation | Immunotherapy - methods | Coculture Techniques | Humans | Hepatitis A Virus Cellular Receptor 2 - metabolism | Tumor Microenvironment | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Antigens, CD - metabolism | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Hepatitis A Virus Cellular Receptor 2 - antagonists & inhibitors | Carcinoma, Hepatocellular - drug therapy | T-Lymphocytes - metabolism | T-Lymphocytes - drug effects | Liver Neoplasms - pathology | Lymphocytes, Tumor-Infiltrating - metabolism | Antineoplastic Agents - pharmacology | Carcinoma, Hepatocellular - immunology | Hepatitis A Virus Cellular Receptor 2 - immunology | Cytokines - metabolism | Antibodies, Monoclonal - pharmacology | Cells, Cultured | Liver Neoplasms - drug therapy | CTLA-4 Antigen - metabolism | Programmed Cell Death 1 Receptor - metabolism | Antibodies, Neutralizing - pharmacology | Liver Neoplasms - immunology | Lymphocytes, Tumor-Infiltrating - drug effects | CTLA-4 Antigen - immunology | Signal Transduction - drug effects | Lymphocyte Activation - drug effects | Carcinoma, Hepatocellular - pathology | Liver Neoplasms - metabolism | T-Lymphocytes - immunology | Cell Proliferation - drug effects | Programmed Cell Death 1 Receptor - immunology | CTLA-4 Antigen - antagonists & inhibitors | Carcinoma, Hepatocellular - metabolism | Lymphocytes, Tumor-Infiltrating - immunology | Viral antibodies | Cell death | Analysis | Melanoma | Antibodies | T cells | Lung cancer, Non-small cell | Cancer | Liver cancer | Dendritic cells | Tumor antigens | Lung cancer | Immunity
Journal Article
Human Reproduction, ISSN 0268-1161, 04/2016, Volume 31, Issue 4, pp. 700 - 711
Abstract STUDY QUESTION Are the immune regulatory molecules programmed cell death-1 (PD-1) and T-cell immunoglobulin mucin-3 (Tim-3) involved in regulating... 
CD4+T | miscarriage | Th2 bias | pregnancy | trophoblast | PD-1 | Tim-3 | ALLOGRAFT-REJECTION | IMMUNITY | PROTECTION | THYMIC STROMAL LYMPHOPOIETIN | OBSTETRICS & GYNECOLOGY | REPRODUCTIVE BIOLOGY | COSTIMULATORY PATHWAYS | CD4(+)T | DIFFERENTIATION | PDL1 | EXHAUSTION | FETOMATERNAL TOLERANCE | Abortion, Habitual - pathology | Fetal Resorption - prevention & control | Coculture Techniques | Humans | Hepatitis A Virus Cellular Receptor 2 - metabolism | Abortion, Habitual - immunology | Fetal Resorption - metabolism | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Th2 Cells - immunology | CD4-Positive T-Lymphocytes - pathology | Abortion, Habitual - metabolism | Pregnancy Trimester, First | Programmed Cell Death 1 Receptor - blood | Th2 Cells - drug effects | Abortion, Induced | CD4-Positive T-Lymphocytes - immunology | Hepatitis A Virus Cellular Receptor 2 - antagonists & inhibitors | Abortion, Habitual - blood | Antibodies, Neutralizing - therapeutic use | Female | Fetal Resorption - pathology | Maternal-Fetal Exchange - drug effects | Th2 Cells - pathology | Immune Tolerance - drug effects | Decidua - immunology | CD4-Positive T-Lymphocytes - metabolism | Cells, Cultured | Hepatitis A Virus Cellular Receptor 2 - blood | Programmed Cell Death 1 Receptor - metabolism | Antibodies, Neutralizing - pharmacology | Decidua - pathology | Fetal Resorption - immunology | Th2 Cells - metabolism | Decidua - metabolism | Pregnancy | Tocolytic Agents - pharmacology | Tocolytic Agents - therapeutic use | Animals | Cell Proliferation - drug effects | Mice | Decidua - drug effects | CD4-Positive T-Lymphocytes - drug effects | Crosses, Genetic
Journal Article
American Journal of Reproductive Immunology, ISSN 1046-7408, 07/2017, Volume 78, Issue 1, pp. e12696 - n/a
ProblemIntrauterine infection caused by viral infection has been implicated to contribute to preterm birth. Hepatitis A virus cellular receptor 2 (HAVCR2)... 
myometrium | foetal membranes | HAVCR | viral infection | inflammation | HAVCR2 | PRETERM DELIVERY | CELLS | IMMUNITY | ACTIVATION | GALECTIN-9/TIM-3 PATHWAY | IMMUNOLOGY | PREGNANCY | MATERNAL-FETAL INTERFACE | TIM-3 EXPRESSION | REPRODUCTIVE BIOLOGY | INFLUENZA-VIRUS | Myometrium - drug effects | RNA, Small Interfering - genetics | Humans | Obstetric Labor, Premature - genetics | Hepatitis A Virus Cellular Receptor 2 - metabolism | Dinoprost - metabolism | RNA, Messenger - metabolism | Pregnancy Complications, Infectious - metabolism | Young Adult | Obstetric Labor, Premature - metabolism | Receptors, Prostaglandin - genetics | Cyclooxygenase 2 - genetics | Myometrium - metabolism | Adult | Female | Vascular Cell Adhesion Molecule-1 - genetics | Virus Diseases - genetics | Poly I-C - pharmacology | Cytokines - metabolism | Virus Diseases - metabolism | Pregnancy | Intercellular Adhesion Molecule-1 - metabolism | Intercellular Adhesion Molecule-1 - genetics | Adolescent | Extraembryonic Membranes - metabolism | Hepatitis A Virus Cellular Receptor 2 - genetics | Pregnancy Complications, Infectious - genetics | Vascular Cell Adhesion Molecule-1 - metabolism | Extraembryonic Membranes - drug effects | Premature birth | Infections | Birth | Cell adhesion molecules | Cell adhesion & migration | Interleukin 6 | Hepatitis | Interleukin 4 | Prostaglandins | Interleukin 1 | Myometrium | Cytokines | Intercellular adhesion molecule 1 | Secretion | Double-stranded RNA | Inflammation | siRNA | Poly (I:C) | Gene expression | Tumor necrosis factor | Interleukin 10 | Amnion | Hepatitis A | Chemokines | Monocyte chemoattractant protein 1 | Viral infections
Journal Article
Journal of Immunology, ISSN 0022-1767, 01/2018, Volume 200, Issue 1, pp. 347 - 354
Therapies targeting immune checkpoint molecules CTLA-4 and PD-1/PD-L1 have advanced the field of cancer immunotherapy. New mAbs targeting different immune... 
HETEROGENEITY | PEMBROLIZUMAB | THERAPY | RECURRENT | PD-1 BLOCKADE | SQUAMOUS-CELL CARCINOMA | IMMUNOLOGY | NIVOLUMAB | SUPPRESSION | CLINICAL ACTIVITY | CANCER | Tumor Necrosis Factor Receptor Superfamily, Member 7 - immunology | Immunotherapy - methods | Antigens, Neoplasm - immunology | Humans | Hepatitis A Virus Cellular Receptor 2 - metabolism | CTLA-4 Antigen - metabolism | Programmed Cell Death 1 Receptor - metabolism | Tumor Microenvironment | Antibodies, Monoclonal - therapeutic use | Neoplasms - diagnosis | CTLA-4 Antigen - immunology | B7-H1 Antigen - immunology | Receptors, OX40 - immunology | Immunohistochemistry - methods | B7-H1 Antigen - metabolism | Neoplasms - therapy | Receptors, OX40 - metabolism | Neoplasms - immunology | Tumor Necrosis Factor Receptor Superfamily, Member 7 - metabolism | Antigens, Neoplasm - metabolism | Biomarkers, Tumor - metabolism | Programmed Cell Death 1 Receptor - immunology | Hepatitis A Virus Cellular Receptor 2 - immunology | Single-Cell Analysis | CD27 antigen | Immunohistochemistry | Multiplexing | Medical research | Tumor markers | PD-1 protein | Immunomodulation | Markers | Spatial discrimination | Color | Clinical trials | CD3 antigen | Paraffin | Modulators | Optimization | CTLA-4 protein | Immune checkpoint | Spatial data | Tumor necrosis factor | Immunotherapy | PD-L1 protein | New combinations | Cancer
Journal Article
Journal Article
Nature Communications, ISSN 2041-1723, 06/2017, Volume 8, Issue 1, p. 15776
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 10/2017, Volume 114, Issue 42, pp. E8865 - E8874
Journal Article
Journal Article
Immunology, ISSN 0019-2805, 01/2018, Volume 153, Issue 1, pp. 71 - 83
The Nod‐like receptor protein 3 ( NLRP 3) inflammasome plays roles in host defence against invading pathogens and in the development of autoimmune damage.... 
NLRP | macrophage | 3 inflammasome | Tim‐3 | NLRP3 inflammasome | Tim-3 | HOMEOSTASIS | INHIBITION | IMMUNE-RESPONSES | MACROPHAGES | DISEASE | SECRETION | IMMUNOLOGY | SUPPRESSION | EXPRESSION | Potassium - metabolism | Inflammasomes - metabolism | Reactive Oxygen Species - metabolism | Humans | Middle Aged | Hepatitis A Virus Cellular Receptor 2 - metabolism | Male | NF-kappa B - metabolism | Interleukin-1beta - genetics | Adenosine Triphosphate - biosynthesis | Case-Control Studies | Young Adult | Peritonitis - pathology | Interleukin-1beta - metabolism | Adult | Female | Caspase 1 | Protein Interaction Domains and Motifs | Macrophages - immunology | Disease Models, Animal | Hepatitis A Virus Cellular Receptor 2 - chemistry | Cell Line | Signal Transduction | NLR Family, Pyrin Domain-Containing 3 Protein - metabolism | Peritonitis - metabolism | NLR Family, Pyrin Domain-Containing 3 Protein - antagonists & inhibitors | Peritonitis - immunology | Macrophages - metabolism | Animals | Inflammasomes - immunology | Protein Binding | Mice | Interleukins | Genetic engineering | T cells | Macrophages | Mitogens | Peritonitis | Efflux | Immunoglobulins | Reactive oxygen species | Interleukin | Aluminum sulfate | Transgenic | Priming | Lymphocytes T | Activation | Cell activation | Mucin | Immune checkpoint | Rodents | Interleukin 1 | Alum | ATP | Original
Journal Article